Aging Influences the Metabolic and Inflammatory Phenotype in an Experimental Mouse Model of Acute Lung Injury.
Acute Lung Injury
/ metabolism
Aging
/ metabolism
Animals
Anorexia
/ metabolism
Cadherins
/ metabolism
Carnitine O-Palmitoyltransferase
/ metabolism
Disease Models, Animal
Energy Metabolism
/ physiology
Enzyme Inhibitors
/ pharmacology
Epoxy Compounds
/ pharmacology
Fatty Acid Transport Proteins
/ metabolism
Fatty Acids
/ metabolism
Mice, Inbred C57BL
Muscle, Skeletal
/ metabolism
Neutrophils
/ metabolism
Oxidation-Reduction
Phenotype
Pulmonary Gas Exchange
/ physiology
Uncoupling Protein 3
/ metabolism
Critical illness
Fats
Inflammation
Nutrition
Journal
The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837
Informations de publication
Date de publication:
30 04 2021
30 04 2021
Historique:
received:
29
04
2020
pubmed:
1
10
2020
medline:
17
8
2021
entrez:
30
9
2020
Statut:
ppublish
Résumé
Increased age is a risk factor for poor outcomes from respiratory failure and acute respiratory distress syndrome (ARDS). In this study, we sought to define age-related differences in lung inflammation, muscle injury, and metabolism after intratracheal lipopolysaccharide (IT-LPS) acute lung injury (ALI) in adult (6 months) and aged (18-20 months) male C57BL/6 mice. We also investigated age-related changes in muscle fatty acid oxidation (FAO) and the consequences of systemic FAO inhibition with the drug etomoxir. Aged mice had a distinct lung injury course characterized by prolonged alveolar neutrophilia and lack of response to therapeutic exercise. To assess the metabolic consequences of ALI, aged and adult mice underwent whole body metabolic phenotyping before and after IT-LPS. Aged mice had prolonged anorexia and decreased respiratory exchange ratio, indicating increased reliance on FAO. Etomoxir increased mortality in aged but not adult ALI mice, confirming the importance of FAO on survival from acute severe stress and suggesting that adult mice have increased resilience to FAO inhibition. Skeletal muscles from aged ALI mice had increased transcription of key fatty acid metabolizing enzymes, CPT-1b, LCAD, MCAD, FATP1 and UCP3. Additionally, aged mice had increased protein levels of CPT-1b at baseline and after lung injury. Surprisingly, CPT-1b in isolated skeletal muscle mitochondria had decreased activity in aged mice compared to adults. The distinct phenotype of aged ALI mice has similar characteristics to the adverse age-related outcomes of ARDS. This model may be useful to examine and augment immunologic and metabolic abnormalities unique to the critically ill aged population.
Identifiants
pubmed: 32997738
pii: 5913453
doi: 10.1093/gerona/glaa248
pmc: PMC8087268
doi:
Substances chimiques
Cadherins
0
Enzyme Inhibitors
0
Epoxy Compounds
0
Fatty Acid Transport Proteins
0
Fatty Acids
0
Slc27a1 protein, mouse
0
Ucp3 protein, mouse
0
Uncoupling Protein 3
0
M-cadherin
142845-03-2
CPT1B protein, mouse
EC 2.3.1.21
Carnitine O-Palmitoyltransferase
EC 2.3.1.21
etomoxir
MSB3DD2XP6
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
770-777Subventions
Organisme : NIDDK NIH HHS
ID : K01 DK117069
Pays : United States
Organisme : NIGMS NIH HHS
ID : K08 GM123322
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG021332
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL076132
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
J Lipid Res. 2009 Oct;50(10):2055-63
pubmed: 19443862
Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E1231-7
pubmed: 17179390
J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):89-101
pubmed: 27897405
Chest. 1997 May;111(5):1334-9
pubmed: 9149591
Nutr Diabetes. 2012 Sep 10;2:e45
pubmed: 23446660
Physiol Res. 2016 Jun 20;65(2):193-207
pubmed: 26447514
N Engl J Med. 2005 Oct 20;353(16):1685-93
pubmed: 16236739
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Am J Respir Crit Care Med. 2016 Oct 1;194(7):831-844
pubmed: 26974173
Diabetes. 2007 Aug;56(8):2085-92
pubmed: 17519422
Sci Rep. 2011;1:79
pubmed: 22355598
Metabolomics. 2016 Aug;12(8):
pubmed: 28217037
Crit Care. 2017 Dec 28;21(Suppl 3):309
pubmed: 29297363
PLoS One. 2016 Sep 14;11(9):e0162167
pubmed: 27627109
Crit Care Med. 2010 Jun;38(6):1450-7
pubmed: 20386308
Virulence. 2014 Jan 1;5(1):66-72
pubmed: 24185508
J Gerontol A Biol Sci Med Sci. 2020 Nov 13;75(12):2258-2261
pubmed: 32173728
Thorax. 2018 Oct;73(10):926-935
pubmed: 29980655
Anal Biochem. 1977 Dec;83(2):346-56
pubmed: 603028
Ann Intern Med. 2002 Jan 1;136(1):25-36
pubmed: 11777361
Expert Rev Respir Med. 2010 Dec;4(6):773-83
pubmed: 21128752
Nutrition. 1997 Sep;13(9 Suppl):45S-51S
pubmed: 9290109
PLoS One. 2015 Sep 16;10(9):e0138389
pubmed: 26375818
Exp Lung Res. 2015 May;41(4):216-27
pubmed: 25844693
J Gerontol A Biol Sci Med Sci. 2016 May;71(5):571-7
pubmed: 25940962
J Clin Invest. 2009 Oct;119(10):2898-913
pubmed: 19770521
JAMA. 1995 Jan 25;273(4):306-9
pubmed: 7815658
Sci Transl Med. 2015 Mar 11;7(278):278ra32
pubmed: 25761888
Free Radic Biol Med. 2011 Jan 15;50(2):371-80
pubmed: 21092756
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
Exp Physiol. 2015 Sep;100(9):1052-63
pubmed: 25998196
Immunol Res. 2015 Dec;63(1-3):209-15
pubmed: 26318747
Am J Respir Crit Care Med. 2016 Dec 1;194(11):1337-1348
pubmed: 27611700
J Clin Invest. 1990 Nov;86(5):1423-7
pubmed: 2243122
J Am Geriatr Soc. 2015 Oct;63(10):2061-9
pubmed: 26415711
N Engl J Med. 2015 Feb 19;372(8):747-55
pubmed: 25693014
Cell Metab. 2017 Sep 5;26(3):509-522.e6
pubmed: 28877455
Am J Respir Crit Care Med. 2012 Apr 15;185(8):825-34
pubmed: 22312013
Am J Respir Crit Care Med. 1994 Jul;150(1):113-22
pubmed: 8025736
FASEB J. 2002 Oct;16(12):1688-90
pubmed: 12206997